Transchem

Transchem Operating Expenses

The Total Operating Expenses of Transchem (500422.BO) as of Oct 20, 2026 is 8.94 M INR. In the previous year, Total Operating Expenses was 6.70 M INR — a change of 33.40% (higher).

Operating Expenses

8.94 MINR

YoY

33.40%

Last updated:

Total Operating Expenses of Transchem is 2026 8.94 M INR. Total Operating Expenses of Transchem was 2025 6.70 M INR. It decreases by 33.40% higher compared to the previous year.

The Transchem Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2019
4.76 M INR
Jan 1, 2020
6.64 M INR
Jan 1, 2021
10.24 M INR
Jan 1, 2022
8.49 M INR
Jan 1, 2023
9.16 M INR
Jan 1, 2024
8.77 M INR
Jan 1, 2025
6.70 M INR
Jan 1, 2026
8.94 M INR
The Transchem Operating Expenses history
YEAROperating ExpensesYoY
8.94 MINR+33.40%
6.70 MINR-23.63%
8.77 MINR-4.25%
9.16 MINR+7.94%
8.49 MINR-17.15%
10.24 MINR+54.27%
6.64 MINR+39.63%
4.76 MINR+18.94%
4.00 MINR+26.17%
3.17 MINR+2.01%
3.11 MINR-60.14%
7.79 MINR-24.69%
10.35 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

Total Operating Expenses of Transchem is 8.94 M INR in 2026.

Total Operating Expenses of Transchem changed from 6.70 M INR to 8.94 M INR, representing a 33.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Transchem since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Transchem historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Transchem

All Key Metrics — Transchem